Alloy Therapeutics and Pfizer to Develop New Antibody Discovery Platform
Pfizer and Alloy have collaborated on various antibody discovery efforts, including the use of Alloy's ATX-CLC platform.
Alloy Therapeutics | 12/02/2025 | By Aishwarya
Alloy Therapeutics Signs License Deal with Takeda to Develop Cell Therapy Platform
Under the agreement, Alloy gains co-exclusive rights to commercialize iCAR-T and iCAR-NK products for oncology indications.
Alloy Therapeutics | 21/11/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy